{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:10:14Z","timestamp":1791850214887,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ymgme.2013.04.008","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T05:36:49Z","timestamp":1366177009000},"page":"116-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Differences between acylcarnitine profiles in plasma and bloodspots"],"prefix":"10.1016","volume":"110","author":[{"given":"Monique G.M.","family":"de Sain-van der Velden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene F.","family":"Diekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith J.","family":"Jans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"van der Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthil H.C.M.T.","family":"Prinsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gepke","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda M.","family":"Verhoeven-Duif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.04.008_bb0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","article-title":"A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation","volume":"33","author":"Houten","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03261931","article-title":"Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects","volume":"51","author":"Reuter","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0015","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1542\/peds.111.6.1399","article-title":"Expanded newborn screening for inborn errors of metabolism by electrospray ionization\u2013tandem mass spectrometry: results, outcome, and implications","volume":"111","author":"Schulze","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.04.008_bb0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","article-title":"Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project","volume":"13","author":"McHugh","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1023\/A:1005587617745","article-title":"Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects","volume":"22","author":"Vreken","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0009-9120(01)00272-7","article-title":"Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS\/MS","volume":"34","author":"Silva","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ymgme.2010.06.012","article-title":"ESI-MS\/MS measurement of free carnitine and its precursor gamma-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders","volume":"101","author":"Primassin","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0065-3101(24)00155-5","article-title":"New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency","volume":"34","author":"Stanley","year":"1987","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jcp.52.9.633","article-title":"The use of the dried blood spot sample in epidemiological studies","volume":"52","author":"Parker","year":"1999","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1023\/A:1005673828469","article-title":"Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency","volume":"23","author":"Van Hove","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0055","first-page":"11","article-title":"Normal levels of plasma free carnitine and acylcarnitines in follow-up samples from a presymptomatic case of carnitine palmitoyl transferase 1 (CPT1) deficiency detected through newborn screening in Denmark","volume":"3","author":"Lund Borch","year":"2012","journal-title":"J. Inherit. Metab Dis. Rep."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0060","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/clinchem\/47.10.1763","article-title":"Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific","volume":"47","author":"Fingerhut","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1015109127986","article-title":"Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry","volume":"25","author":"Gempel","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0070","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-012-9483-0","article-title":"Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1 \u2014 from blood spot to screening result","author":"Loeber","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ymgme.2011.05.003","article-title":"Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy\u2013Walker syndrome and sudden death","volume":"104","author":"Yahyaoui","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s10545-007-0642-7","article-title":"A retrospective ESI-MS\/MS analysis of newborn blood spots from 18 symptomatic patients with organic acid and fatty acid oxidation disorders diagnosed either in infancy or in childhood","volume":"30","author":"Kobayashi","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ymgme.2005.12.012","article-title":"VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis","volume":"88","author":"Boneh","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00216-012-6194-1","article-title":"A rapid UPLC-MS\/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening","volume":"404","author":"Gucciardi","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0095","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1542\/peds.2010-3918","article-title":"Siblings with mitochondrial acetoacetyl-CoA thiolase deficiency not identified by newborn screening","volume":"128","author":"Sarafoglou","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.04.008_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10545-006-0228-9","article-title":"The tandem mass spectrometry newborn screening experience in North Carolina: 1997\u20132005","volume":"29","author":"Frazier","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0105","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ymgme.2011.09.021","article-title":"Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme","volume":"104","author":"Couce","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.04.008_bb0110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.medcli.2011.10.007","article-title":"Expanded newborn screening in the Region of Murcia, Spain. Three-years experience","volume":"139","author":"Juan-Fita","year":"2012","journal-title":"Med. Clin. (Barc.)"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T02:01:49Z","timestamp":1715220109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1096719213001340"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.04.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences between acylcarnitine profiles in plasma and bloodspots","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}